Accessibility Menu
 
Medical Developments International logo

Medical Developments International

(ASX) MVP

Current Price$0.41
Market Cap$43.94M
Since IPO (2003)+4%
5 Year-92%
1 Year-23%
1 Month-5%

Medical Developments International Financials at a Glance

Market Cap

$43.94M

Revenue (TTM)

$78.69M

Net Income (TTM)

$30.18M

EPS (TTM)

$-0.00

P/E Ratio

-100.00

Dividend

$0.00

Beta (Volatility)

0.21 (Low)

Price

$0.41

Volume

51,550

Open

$0.39

Previous Close

$0.41

Daily Range

$0.39 - $0.42

52-Week Range

$0.36 - $0.77

MVP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Medical Developments International

Industry

Pharmaceuticals

Employees

68

CEO

Brent MacGregor, MBA

Headquarters

Scoresby, VIC 3179, AU

MVP Financials

Key Financial Metrics (TTM)

Gross Margin

53%

Operating Margin

1%

Net Income Margin

-1%

Return on Equity

-79%

Return on Capital

1%

Return on Assets

-1%

Earnings Yield

-1.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$43.94M

Shares Outstanding

112.66M

Volume

51.55K

Short Interest

0.00%

Avg. Volume

103.58K

Financials (TTM)

Gross Profit

$29.43M

Operating Income

$3.07M

EBITDA

$1.67M

Operating Cash Flow

$43.00K

Capital Expenditure

$443.00K

Free Cash Flow

$486.00K

Cash & ST Invst.

$17.84M

Total Debt

$1.99M

Medical Developments International Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$21.57M

+43.0%

Gross Profit

$6.71M

+223.2%

Gross Margin

31.13%

N/A

Market Cap

$43.94M

N/A

Market Cap/Employee

$646.13K

N/A

Employees

68

N/A

Net Income

$226.00K

+97.9%

EBITDA

$1.33M

+111.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$13.54M

+2.0%

Accounts Receivable

$7.48M

+54.5%

Inventory

$8.49M

-10.6%

Long Term Debt

$3.01M

+45.9%

Short Term Debt

$330.00K

-9.6%

Return on Assets

-0.69%

N/A

Return on Invested Capital

0.58%

N/A

Free Cash Flow

$62.00K

+100.8%

Operating Cash Flow

$284.00K

+104.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NXS.AXNext Science Limited
$0.14+0.00%
RAD.AXRadiopharm Theranostics Limited
$0.02+0.00%
MX1.AXMicro-X Limited
$0.05-1.92%
PCK.AXPainChek Limited
$0.16+3.23%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.23+0.04%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$77.45-0.04%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.77+0.05%
CYCNCyclerion Therapeutics
$6.38+3.12%

Questions About MVP

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.